4//SEC Filing
Booth Andrew 4
Accession 0001628280-25-000233
CIK 0001703057other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:37 PM ET
Size
5.6 KB
Accession
0001628280-25-000233
Insider Transaction Report
Form 4
Booth Andrew
Chief Financial Officer
Transactions
- Award
Share option (right to buy)
2025-01-01+1,352,054→ 7,942,951 totalExercise: $2.93Exp: 2035-01-01→ Common Shares (1,352,054 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834411
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 3:37 PM ET
- Size
- 5.6 KB